Statin Therapy to Improve Prostate Cancer Outcomes: Who, When, and for How Long?

Eur Urol. 2018 Dec;74(6):702-703. doi: 10.1016/j.eururo.2018.08.012. Epub 2018 Aug 31.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Atorvastatin*
  • Double-Blind Method
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors*
  • Male
  • Prostatectomy
  • Prostatic Neoplasms / surgery

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Atorvastatin